Health
Cats point the way to potential COVID-19 remedies – FierceBiotech
University of Alberta scientists reported that a drug being developed by Anivive Lifesciences to treat feline infectious peritonitis prevented human coronaviruses from replicating in cell studies. They believe the drug should be rushed into human trials to tr…
Last week, Gilead Sciences said it would test its COVID-19 drug remdesivir against a related compound in its library called GS-441524 in animal trials, after facing scrutiny over the latter drug, which has been used for years to treat feline infectious peritonitis (FIP) despite not being licensed for that use.
Now, another California biotech, Anivive Lifesciences, is working on a COVID-19 antiviral drug thats inspired by cats, and it has new preclinical research findings to back up the project….
-
General19 hours agoAustralia urged to spearhead regional carbon tariffs
-
Noosa News8 hours agoWinter cold snap heralds beginning of south-east Queensland dry season
-
General16 hours agoGippsland communities fear erosion protection not coping with rising tides
-
Business16 hours ago5 things to watch on the ASX 200 on Thursday 5 June 2025